Erratum: Intrahepatic Transcriptional Signature Associated with Response to Interferon-α Treatment in the Woodchuck Model of Chronic Hepatitis B (PLoS Pathogens (2015) 11:9 (e1005103) DOI: 10.1371/journal.ppat.1005103);Intrahepatic Transcriptional Signature Associated with Response to Interferon-α Treatment in the Woodchuck Model of Chronic Hepatitis B

PLoS Pathogens

Volumn 11, Issue 9, 2015, Pages 1-30

  Fletcher, Simon P ^a,e   Chin, Daniel J ^a,f   Gruenbaum, Lore ^a,g   Bitter, Hans ^a,h   Rasmussen, Erik ^a,i   Ravindran, Palanikumar ^a,j   Swinney, David C ^a,k   Birzele, Fabian ^b   Schmucki, Roland ^c   Lorenz, Stefan H ^b   Kopetzki, Erhard ^b   Carter, Jade ^a,l   Triyatni, Miriam ^c   Thampi, Linta M ^d   Yang, Junming ^d   AlDeghaither, Dalal ^d   Murredu, Marta G ^d   Cote, Paul ^d   Menne, Stephan ^d  

^a HOFFMANN LA ROCHE INC   (United States)

^b ROCHE INNOVATION CENTER MUNICH   (Germany)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^e GILEAD SCIENCES   (United States)

^f Quanticel Pharmaceuticals   (United States)

^g Roche Innovation Center New York   (United States)

^h NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

ⁱ REGENERON PHARMACEUTICALS INC   (United States)

^j BRISTOL MYERS SQUIBB   (United States)

^k IRND3   (United States)

^l NEW YORK GENOME CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3H; ASPARTATE AMINOTRANSFERASE; CD8 ANTIGEN; CXCL9 CHEMOKINE; NATURAL KILLER CELL LECTIN LIKE RECEPTOR; PLACEBO; PROGRAMMED DEATH 1 RECEPTOR; RECOMBINANT ALPHA INTERFERON; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG; ALPHA INTERFERON; ANTIVIRUS AGENT; BIOLOGICAL MARKER; IMMUNOLOGIC FACTOR; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC HEPATITIS B; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; LIVER BIOPSY; MASS SPECTROMETRY; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE DRUG DOSE; SOUTHERN BLOTTING; TRANSCRIPTOMICS; TREATMENT RESPONSE; VIRUS IMMUNITY; WOODCHUCK HEPATITIS; WOODCHUCK HEPATITIS VIRUS; ANIMAL; BIOPSY; BLOOD; CELLULAR IMMUNITY; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GENETICS; HEPATITIS B, CHRONIC; IMMUNOLOGY; LIVER; MALE; MARMOTA; METABOLISM; NATURAL KILLER CELL; PATHOLOGY; T LYMPHOCYTE; VETERINARY; VIROLOGY; VIRUS LOAD;

ANIMALS; ANTIVIRAL AGENTS; BIOMARKERS; BIOPSY; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION PROFILING; HEPATITIS B VIRUS, WOODCHUCK; HEPATITIS B, CHRONIC; IMMUNITY, CELLULAR; IMMUNOLOGIC FACTORS; INTERFERON-ALPHA; KILLER CELLS, NATURAL; LIVER; MALE; MARMOTA; RECOMBINANT PROTEINS; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC; VIRAL LOAD;

EID: 84943533132     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005541     Document Type: Erratum

References (65)

1. Lavanchy D, (2004) Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 11: 97–107. 14996343
2. Kwon H, Lok AS, (2011) Hepatitis B therapy. Nat Rev Gastroenterol Hepatol 8: 275–284. doi: 10.1038/nrgastro.2011.33 21423260
3. Rehermann B, Bertoletti A, (2015) Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections. Hepatology 61: 712–721. doi: 10.1002/hep.27323 25048716
4. Schoggins JW, Rice CM, (2011) Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol 1: 519–525. doi: 10.1016/j.coviro.2011.10.008 22328912
5. Swiecki M, Colonna M, (2011) Type I interferons: diversity of sources, production pathways and effects on immune responses. Curr Opin Virol 1: 463–475. doi: 10.1016/j.coviro.2011.10.026 22440910
6. Wieland SF, Eustaquio A, Whitten-Bauer C, Boyd B, Chisari FV, (2005) Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids. Proc Natl Acad Sci U S A 102: 9913–9917. 15994231
7. Anderson AL, Banks KE, Pontoglio M, Yaniv M, McLachlan A, (2005) Alpha/beta interferon differentially modulates the clearance of cytoplasmic encapsidated replication intermediates and nuclear covalently closed circular hepatitis B virus (HBV) DNA from the livers of hepatocyte nuclear factor 1alpha-null HBV transgenic mice. J Virol 79: 11045–11052. 16103155
8. Xu C, Guo H, Pan XB, Mao R, Yu W, et al. (2010) Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus. J Virol 84: 9332–9340. doi: 10.1128/JVI.00918-10 20610715
9. Li N, Zhang L, Chen L, Feng W, Xu Y, et al. (2012) MxA inhibits hepatitis B virus replication by interaction with hepatitis B core antigen. Hepatology 56: 803–811. doi: 10.1002/hep.25608 22271421
10. Yan R, Zhao X, Cai D, Liu Y, Block T, et al. (2015) Interferon-inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion. J Virol.
11. Belloni L, Allweiss L, Guerrieri F, Pediconi N, Volz T, et al. (2012) IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. J Clin Invest 122: 529–537. doi: 10.1172/JCI58847 22251702
12. Liu F, Campagna M, Qi Y, Zhao X, Guo F, et al. (2013) Alpha-interferon suppresses hepadnavirus transcription by altering epigenetic modification of cccDNA minichromosomes. PLoS Pathog 9: e1003613. doi: 10.1371/journal.ppat.1003613 24068929
13. Lucifora J, Xia Y, Reisinger F, Zhang K, Stadler D, et al. (2014) Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. Science 343: 1221–1228. doi: 10.1126/science.1243462 24557838
14. Allweiss L, Volz T, Lutgehetmann M, Giersch K, Bornscheuer T, et al. (2014) Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration. J Hepatol 60: 500–507. doi: 10.1016/j.jhep.2013.10.021 24398036
15. Robek MD, Garcia ML, Boyd BS, Chisari FV, (2007) Role of immunoproteasome catalytic subunits in the immune response to hepatitis B virus. J Virol 81: 483–491. 17079320
16. Penna A, Laccabue D, Libri I, Giuberti T, Schivazappa S, et al. (2012) Peginterferon-alpha does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis. J Hepatol 56: 1239–1246. doi: 10.1016/j.jhep.2011.12.032 22326467
17. Micco L, Peppa D, Loggi E, Schurich A, Jefferson L, et al. (2013) Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B. J Hepatol 58: 255–233.
18. Tan AT, Hoang LT, Chin D, Rasmussen E, Lopatin U, et al. (2014) Reduction of HBV replication prolongs the early immunological response to IFNalpha therapy. J Hepatol 60: 54–61. doi: 10.1016/j.jhep.2013.08.020 23994382
19. Stelma F, de Niet A, Tempelmans Plat-Sinnige MJ, Jansen L, Takkenberg RB, et al. (2015) NK Cell Characteristics in Chronic Hepatitis B Patients are Associated with HBsAg Loss after Combination Treatment with Peg-interferon Alpha-2a and Adefovir. J Infect Dis.
20. Jansen L, de Niet A, Makowska Z, Dill MT, van Dort KA, et al. (2014) An intrahepatic transcriptional signature of enhanced immune activity predicts response to peginterferon in chronic hepatitis B. Liver Int.
21. Menne S, Cote PJ, (2007) The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection. World J Gastroenterol 13: 104–124. 17206759
22. Korba BE, Cote P, Hornbuckle W, Schinazi R, Gangemi JD, et al. (2000) Enhanced antiviral benefit of combination therapy with lamivudine and alpha interferon against WHV replication in chronic carrier woodchucks. Antivir Ther 5: 95–104. 10971862
23. Fiedler M, Rodicker F, Salucci V, Lu M, Aurisicchio L, et al. (2004) Helper-dependent adenoviral vector-mediated delivery of woodchuck-specific genes for alpha interferon (IFN-alpha) and IFN-gamma: IFN-alpha but not IFN-gamma reduces woodchuck hepatitis virus replication in chronic infection in vivo. J Virol 78: 10111–10121. 15331744
24. Fletcher SP, Chin DJ, Ji Y, Iniguez AL, Taillon B, et al. (2012) Transcriptomic analysis of the woodchuck model of chronic hepatitis B. Hepatology 56: 820–830. doi: 10.1002/hep.25730 22431061
25. Fletcher SP, Chin DJ, Cheng DT, Ravindran P, Bitter H, et al. (2013) Identification of an intrahepatic transcriptional signature associated with self-limiting infection in the woodchuck model of hepatitis B. Hepatology 57: 13–22. doi: 10.1002/hep.25954 22806943
26. Berraondo P, Garcia-Navarro R, Gonzalez-Aseguinolaza G, Vales A, Blanco-Urgoiti B, et al. (2002) The woodchuck interferon-alpha system: Cloning, family description, and biologic activity. J Med Virol 68: 424–432. 12226832
27. Berraondo P, Crettaz J, Ochoa L, Vales A, Ruiz J, et al. (2009) Production of recombinant woodchuck IFNalpha and development of monoclonal antibodies. J Interferon Cytokine Res 29: 75–82. doi: 10.1089/jir.2008.0012 19014334
28. Wang C, Gong B, Bushel PR, Thierry-Mieg J, Thierry-Mieg D, et al. (2014) The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance. Nat Biotechnol 32: 926–932. doi: 10.1038/nbt.3001 25150839
29. Chaussabel D, Quinn C, Shen J, Patel P, Glaser C, et al. (2008) A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 29: 150–164. doi: 10.1016/j.immuni.2008.05.012 18631455
30. Kurktschiev PD, Raziorrouh B, Schraut W, Backmund M, Wachtler M, et al. (2014) Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction. J Exp Med 211: 2047–2059. doi: 10.1084/jem.20131333 25225458
31. Knox JJ, Cosma GL, Betts MR, McLane LM, (2014) Characterization of T-bet and eomes in peripheral human immune cells. Front Immunol 5: 217. doi: 10.3389/fimmu.2014.00217 24860576
32. Wieland S, Thimme R, Purcell RH, Chisari FV, (2004) Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci U S A 101: 6669–6674. 15100412
33. Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, et al. (2002) Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 196: 459–468. 12186838
34. Sonneveld MJ, Rijckborst V, Boucher CA, Hansen BE, Janssen HL, (2010) Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline. Hepatology 52: 1251–1257. doi: 10.1002/hep.23844 20830787
35. Salucci V, Lu M, Aurisicchio L, La Monica N, Roggendorf M, et al. (2002) Expression of a new woodchuck IFN-alpha gene by a helper-dependent adenoviral vector in woodchuck hepatitis virus-infected primary hepatocytes. J Interferon Cytokine Res 22: 1027–1034. 12433282
36. Zhu Y, Qin B, Xiao C, Lu X, Chen L, (2012) Cell-type specific interferon stimulated gene staining in liver underlies response to interferon therapy in chronic HBV infected patients. Dig Dis Sci 57: 2355–2361. doi: 10.1007/s10620-012-2169-5 22585383
37. Lutgehetmann M, Bornscheuer T, Volz T, Allweiss L, Bockmann JH, et al. (2011) Hepatitis B virus limits response of human hepatocytes to interferon-alpha in chimeric mice. Gastroenterology 140: 2074–2083, 2083 e2071–2072. doi: 10.1053/j.gastro.2011.02.057 21376046
38. Flink HJ, Sprengers D, Hansen BE, van Zonneveld M, de Man RA, et al. (2005) Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon {alpha}-2b therapy. Gut 54: 1604–1609. 15923670
39. Peppa D, Micco L, Javaid A, Kennedy PT, Schurich A, et al. (2010) Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection. PLoS Pathog 6: e1001227. doi: 10.1371/journal.ppat.1001227 21187913
40. Tjwa ET, van Oord GW, Hegmans JP, Janssen HL, Woltman AM, (2011) Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B. J Hepatol 54: 209–218. doi: 10.1016/j.jhep.2010.07.009 21095036
41. Peppa D, Gill US, Reynolds G, Easom NJ, Pallett LJ, et al. (2013) Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion. J Exp Med 210: 99–114. doi: 10.1084/jem.20121172 23254287
42. Xu HC, Grusdat M, Pandyra AA, Polz R, Huang J, et al. (2014) Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity. Immunity 40: 949–960. doi: 10.1016/j.immuni.2014.05.004 24909887
43. Crouse J, Bedenikovic G, Wiesel M, Ibberson M, Xenarios I, et al. (2014) Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1. Immunity 40: 961–973. doi: 10.1016/j.immuni.2014.05.003 24909889
44. Maini MK, Boni C, Lee CK, Larrubia JR, Reignat S, et al. (2000) The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 191: 1269–1280. 10770795
45. Kakimi K, Lane TE, Wieland S, Asensio VC, Campbell IL, et al. (2001) Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. J Exp Med 194: 1755–1766. 11748277
46. Cote PJ, Korba BE, Miller RH, Jacob JR, Baldwin BH, et al. (2000) Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection. Hepatology 31: 190–200. 10613745
47. Menne S, Butler SD, George AL, Tochkov IA, Zhu Y, et al. (2008) Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection. Antimicrob Agents Chemother 52: 3617–3632. doi: 10.1128/AAC.00654-08 18676881
48. Cote PJ, Roneker C, Cass K, Schodel F, Peterson D, et al. (1993) New enzyme immunoassays for the serologic detection of woodchuck hepatitis virus infection. Viral Immunol 6: 161–169. 8216715
49. Peek SF, Cote PJ, Jacob JR, Toshkov IA, Hornbuckle WE, et al. (2001) Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-beta, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax). Hepatology 33: 254–266. 11124844
50. Jacob JR, Korba BE, Cote PJ, Toshkov I, Delaney WEt, et al. (2004) Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model. Antiviral Res 63: 115–121. 15302140
51. Grabherr MG, Haas BJ, Yassour M, Levin JZ, Thompson DA, et al. (2011) Full-length transcriptome assembly from RNA-Seq data without a reference genome. Nat Biotechnol 29: 644–652. doi: 10.1038/nbt.1883 21572440
52. de la Bastide M, McCombie WR, (2007) Assembling genomic DNA sequences with PHRAP. Curr Protoc Bioinformatics Chapter 11: Unit11 14.
53. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ, (1990) Basic local alignment search tool. J Mol Biol 215: 403–410. 2231712
54. Needleman SB, Wunsch CD, (1970) A general method applicable to the search for similarities in the amino acid sequence of two proteins. J Mol Biol 48: 443–453. 5420325
55. Huang X, Madan A, (1999) CAP3: A DNA sequence assembly program. Genome Res 9: 868–877. 10508846
56. Langmead B, Trapnell C, Pop M, Salzberg SL, (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25. doi: 10.1186/gb-2009-10-3-r25 19261174
57. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, et al. (2009) The Sequence Alignment/Map format and SAMtools. Bioinformatics 25: 2078–2079. doi: 10.1093/bioinformatics/btp352 19505943
58. Anders S, Huber W, (2010) Differential expression analysis for sequence count data. Genome Biol 11: R106. doi: 10.1186/gb-2010-11-10-r106 20979621
59. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Statist Soc Ser B (Methodological) 57: 289–300.
60. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545–15550. 16199517
61. Langfelder P, Horvath S, (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9: 559. doi: 10.1186/1471-2105-9-559 19114008
62. Menne S, Wang Y, Butler SD, Gerin JL, Cote PJ, et al. (2002) Real-time polymerase chain reaction assays for leukocyte CD and cytokine mRNAs of the Eastern woodchuck (Marmota monax). Vet Immunol Immunopathol 87: 97–105. 12052347
63. Wang Y, Jacob JR, Menne S, Bellezza CA, Tennant BC, et al. (2004) Interferon-gamma-associated responses to woodchuck hepatitis virus infection in neonatal woodchucks and virus-infected hepatocytes. J Viral Hepat 11: 404–417. 15357645
64. Lu Y, Xu Y, Yang D, Kemper T, Roggendorf M, et al. (2008) Molecular characterization of woodchuck type I interferons and their expression by woodchuck peripheral blood lymphocytes. Cytokine 41: 127–135. 18096400
65. Crettaz J, Otano I, Ochoa L, Benito A, Paneda A, et al. (2009) Treatment of chronic viral hepatitis in woodchucks by prolonged intrahepatic expression of interleukin-12. J Virol 83: 2663–2674. doi: 10.1128/JVI.02384-08 19116251